Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE
Patrick Schöffski, Michaela Kubičková, Agnieszka Woźniak, Jean‐Yves Blay, Sandra J. Strauss, Silvia Stacchiotti, Tomasz Świtaj, Veit Bücklein, Michael Leahy, Antoîne Italiano, Nicolás Isambert, Maria Dêbiec‐Rychter, Raf Sciot, Che‐Jui Lee, Frank M. Speetjens, Axelle Nzokirantevye, Anouk Neven, Bernd Kasper
Topics & Concepts
CrizotinibMedicineOncologyInternal medicineTerm (time)Lung cancerQuantum mechanicsMalignant pleural effusionPhysicsIgG4-Related and Inflammatory DiseasesFibroblast Growth Factor ResearchCholangiocarcinoma and Gallbladder Cancer Studies